Webinar: Validated bioassays for metabolic & gastrointestinal diseases: Accelerating development of

<March 2023>
SunMonTueWedThuFriSat
26
 
27
 
28
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
Webinar: Validated bioassays for meta...
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
31
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 

Webinar: Validated bioassays for metabolic & gastrointestinal diseases: Accelerating development of GLP-1 & -2 therapeutics

 

There is a tremendous need to generate therapeutics targeting metabolic and gastrointestinal diseases. By targeting GPCRs, glucagon-like peptide (GLP-1 and GLP-2) receptors, therapeutics can be developed to address these globally prevalent medical disorders. In particular, engineered recombinant agonist analogues targeting the GLP-1 receptor are FDA approved for managing type 2 diabetes, obesity and body weight disorders, while GLP-2 analogues have been under therapeutic focus for the treatment of short bowel syndrome, a serious unmet medical disorder. Several other novel GLP analogues, including biosimilar and biobetters, are in clinical development; however, existing assays for characterising their mechanism-of-actions (MOAs) are complex and require extensive development time.


Register Now
Event capacity: N/A
Event location:
Event date: 3/22/2023, 8:00 AM - 8:00 PM
No data found
Event Date ▼ Event Name PDF Link Webinar Link
March 22, 2023 Webinar: Validated bioassays for metabolic & gastrointestinal diseases: Accelerating development of GLP-1 & -2 therapeutics
July 28, 2022 Roundtable Webinar: Accelerating Your Biologics Therapeutics Development with Bioassays
June 16, 2022 Webinar: Cytotoxicity Bioassays – Measuring Antibody-Mediated Direct Cell Death
February 23, 2022 Webinar: Unlocking Orphan GPCRs with an Innovative Forward Trafficking Approach – 45 min. + 30 min. Q&A
July 28, 2021 Webinar: Automating Functional Cell-based Bioassays: Assay Reproducibility and Performance for Potency Testing Programs - 45 min.
March 30, 2021 Webinar: Novel Small Molecule Inhibitors of Oncogenic SHP2 Variants Characterized by Cellular Target Engagement - 45 min.
October 28, 2020 Webinar: Accelerating COVID-19 Drug Discovery: Qualified Cell-Based Assays for Proinflammatory Cytokines - 45 min.
June 17, 2020 Webinar: Simple Signaling Reporter Assays – Easily Quantify Activation & Inhibition of Cellular Pathways - 30 min.
October 9, 2019 Webinar: Establishing Qualified Bioassays for Checkpoint Receptors to Implement in QC Lot Release: Case Studies on PD-1 and SIRPα - 60 min.